Advanced Cardiovascular Imaging Consortium (ACIC)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00640068|
Recruitment Status : Completed
First Posted : March 20, 2008
Last Update Posted : April 3, 2014
|Condition or disease|
|Chest Pain Coronary Occlusion Coronary Artery Disease|
This study is a collaborative quality assurance initiative organized by Blue Cross Blue Shield of Michigan and Blue Cross Network (BCBSM/BCN) for initiation of insurance coverage of coronary artery CT scanning (CCTA), a relatively new procedure that can provide non-invasive coronary angiograms. While this procedure has promise in that it can rapidly diagnose patients with unknown chest pain and reduce the cost of medical care, there is substantial potential for abuse and excess cost and inappropriate care if not appropriately used.
The Consortium's objectives are to educate participating sites of the clinical uses of CCTA as well as other best-practice recommendations; to create a database (Registry) to develop evidence of the best-practice utilization of CCTA; to provide a feedback mechanism to the sites about the positive or negative evidence of best-practice utilization of CCTA; to develop strategies to improve the utilization of CCTA; to monitor the CQI process of the individual participating sites; to reduce cost and improve safety and efficiency in in the care of patients with acute chest pain, indeterminate stress tests results, and to assess coronary bypass graft patency.
|Study Type :||Observational|
|Actual Enrollment :||42926 participants|
|Official Title:||Advanced Cardiovascular Imaging Consortium: A Collaborative Quality Improvement Project|
|Study Start Date :||July 2007|
|Actual Primary Completion Date :||April 2014|
|Actual Study Completion Date :||April 2014|
All patients in whom a clinical CCTA was ordered by their physician at a participating site. Patient must have a prescription for CCTA ordered by their physician.
- Educate participating sites on appropriate use of CCTA [ Time Frame: 5 years ]To educate participating sites in the clinical uses of CCTA recommended by the ACC/ACR as well as other best-practices
- To monitor the CQI process of individual participating sites and the ACIC as a whole. [ Time Frame: 5 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00640068
|Study Director:||Kavitha Chinnaiyan, MD||William Beaumont Hospitals|